Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr

Journal of Virology

Volumn 74, Issue 22, 2000, Pages 10650-10657

  Singh, S P ^a   Tomkowicz, B ^a   Lai, D ^a   Cartas, M ^a   Mahalingam, S ^a   Kalyanaraman, V S ^a   Murali, R ^a   Srinivasan, A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MUTANT PROTEIN; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CELL CYCLE; CELLULAR DISTRIBUTION; GENE DELETION; GENE EXPRESSION SYSTEM; GENE INSERTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN POLYMERIZATION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TRANSPORT; STRUCTURE ACTIVITY RELATION; VIRUS PARTICLE;

AMINO ACID SEQUENCE; CELL CYCLE; GENE PRODUCTS, VPR; HELA CELLS; HIV-1; HUMANS; MUTATION; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; SUBCELLULAR FRACTIONS; TRANSFECTION; VIRION;

EID: 0033755616     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.22.10650-10657.2000     Document Type: Article

References (59)

1. A C-terminal domain of HIV-1 accessory protein Vpr is involved in penetration, mitochondrial dysfunction and apoptosis of human CD4+ lymphocytes
2. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB
3. Distinct effects in primary macrophages and lymphocytes of human immunodeficiency virus type 1 accessory genes vpr, vpu and nef: Mutational analysis of a primary HIV-1 isolate
4. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme
5. Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins
6. Characterization of human immunodeficiency virus type 1 Vif particle incorporation
7. Human immunodeficiency virus vpr product is a virion-associated regulatory protein
8. Identification of HIV-1 Vpr product and function
9. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
10. HIV-1 auxiliary proteins: Making connections in a dying cell
11. Highly purified human immunodeficiency virus type 1 reveals virtual absence of Vif in virions
12. Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficiency virus type 1 Vpr
13. HIV-1 Vpr and the cell cycle
14. HIV transcriptional activation by the accessory protein, Vpr, is mediated by the p300 co-activator
15. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex
16. HIV-1 Vpr increases viral expression by manipulation of the cell cycle - A mechanism for selection of Vpr in vivo
17. HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr
18. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
19. Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2
20. Macromolecular interactions in the assembly of HIV and other retroviruses
21. Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins
22. The p6(gag) domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous virus particles
23. Extent of incorporation of HIV-1 Vpr into the virus particles is flexible and can be modulated by expression level in cells
24. Requirement of the Pr55(gag) precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles
25. Induction of cell differentiation by human immunodeficiency virus 1 vpr
26. Pathogenesis of human immunodeficiency virus infection
27. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions
28. Structural studies of synthetic peptide fragments derived from the HIV-1 Vpr protein
29. A domain of human immunodeficiency virus type-1 Vpr containing repeated H(S/F)RIG amino acid causes cell growth arrest and structural defects
30. Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation
31. Mutagenesis of the putative a-helical domain of the Vpr protein of human immunodeficiency virus type 1: Effect on stability and virion incorporation
32. Role of the conserved dipeptide Gly75 and Cys76 on HIV-1 Vpr function
33. Functional analysis of HIV-1 Vpr: Identifcation of determinants essential for subcellular localization
34. The carboxy terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles
35. The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells
36. Production of uninfectious human immunodeficiency virus type 1 containing viral protein R fused to a single-chain antibody against viral integrase
37. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis
38. Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers
39. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents
40. The glucocorticoid receptor type II complex is a target of the HIV-1 Vpr gene product
41. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection
42. Evidence for direct association of Vpr and Matrix protein p17 within the HIV-1 virion
43. NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: Molecular insights into its biological functions
44. Epitope-based assay to determine the efficiency of cleavage by HIV-1 protease
45. Development of a novel anti-HIV-1 agent from within: Effect of chimeric Vpr containing protease cleavage site residues on virus replication
46. Epitope-tagging approach to determine the stoichiometry of the structural and nonstructural proteins in the virus particles: Amount of Vpr in relation to Gag in HIV-1
47. Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: Implications for priming of HIV-1 reverse transcription
48. Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:Vpr
49. Particle assembly and Vpr expression in human immunodeficiency virus type 1 infected cells demonstrated by immunoelectron microscopy
50. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat
51. NMR structure of the (1-51) N-terminal domain of the HIV-1 regulatory protein Vpr
52. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase
53. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx
54. Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells
55. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: Role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation
56. Biochemical mechanism of HIV-1 Vpr function: Specific interaction with a cellular protein
57. Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain